Valued at $310.0M at its Series A, Jan 2026. Nothing has traded since.
- ·Post-money valuations for 4 rounds
- ·The complete investor list: 29 names
- ·Watch Neurophos: the Monday email on marks, rounds and moves
Valuation timeline
3 priced rounds · 32 daily marks since · Jun 2021 – Oct 2026Membership and data by Private Market View
Neurophos funding history
5 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jan 2026 | Later Stage VC (Series A) | $109.2M | ▮ | ▮ |
| Mar 2024 | Seed Round | $7.2M | ▮ | ▮ |
| Nov 2023 | Accelerator/Incubator | — | ▮ | ▮ |
| Jun 2021 | Seed Round | $1.8M | ▮ | ▮ |
| — | Seed Round | $1.0M | ▮ | ▮ |
Membership and data by Private Market View
Neurophos valuation
Neurophos was valued at $310 million at its Series A in Jan 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Neurophos raised?
Neurophos has raised $119 million across 5 recorded rounds since 2021. The largest was a $7.2 million seed round in Mar 2024; the most recent was a $109 million Series A in Jan 2026. 4 of the rounds disclosed a post-money valuation.
Neurophos has filed 1 Form D with the SEC, most recently in Mar 2026 ($109 million sold to 44 investors).
Institutional holders and vehicles
In the last 12 months, 4 investment vehicles were formed to buy Neurophos shares, reporting $4.1 million sold to 163 investors across 4 sponsors, per SEC Form D filings (most recent Dec 2025).
How Neurophos's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Neurophos, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Neurophos
- What is Neurophos worth?
- Neurophos is valued at $310.0M as of Oct 2026. Valued at $310.0M at its Series A, Jan 2026. Nothing has traded since.
- How much has Neurophos raised?
- Neurophos has raised $119.2M in total funding across 5 recorded rounds.
- When did Neurophos last raise?
- Neurophos last raised in Jan 2026 (Later Stage VC (Series A)), raising $109.2M.